SHOULDER INNOVATIONS, INC.(SI)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #2,529 of 2,961 stocks
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
Unusual Activity in SI
Events flagged as statistical outliers against SI's own multi-year baseline — not fixed dollar thresholds.
SI Stock Analysis & AI Quality Score
Data updated 2026-09-11AI stock analysis and institutional research for SHOULDER INNOVATIONS, INC. (SI), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores SI at 29.5/100 on a 32-signal composite quality model, placing it at rank #2,529 of 2,961 stocks — the bottom half of the AI-ranked universe. SI scores in the top quartile across revenue growth (86.4). Areas of concern include free cash flow (7.3) and balance sheet strength (7.7), which score below median versus the broader universe. Shareholder dilution risk is elevated at 39.4/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), SHOULDER INNOVATIONS, INC. reports quarterly revenue of $17.2M, net income of $-10.2M, an operating margin of -58.4%. Top institutional holders of SI by reported 13-F value include FMR, BlackRock, SECTORAL ASSET MANAGEMENT, based on the most recent SEC filings. SI trades on the NYSE exchange and files with the SEC under CIK 1699350. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate SI daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for SHOULDER INNOVATIONS, INC. directly from SEC EDGAR. SHOULDER INNOVATIONS, INC.'s 13F Pro composite quality score has ranged between 28 and 34 since 2026, currently 29.5 — a declining long-term trajectory across 36 quarterly and live scoring snapshots.
Revenue
Q2 2026
$17.2M
Net Income
Q2 2026
$-10.2M
Free Cash Flow
Q2 2026
$-9.5M
Operating Margin
Q2 2026
-58.4%
ROIC
Q2 2026
-28.8%
D/E Ratio
Q2 2026
0.12
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · ProRevenue
+49.6% YoYNet Income
-158.4% YoYOperating Income
-79.5% YoYEPS (Diluted)
+98.1% YoYTotal Assets
+294.4% YoYTotal Debt
+1.7% YoYOp. Cash Flow
-102.3% YoYFree Cash Flow
-98.4% YoY| Metric | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Revenue | $47.3M +49.6% | $31.6M | — |
| Net Income | $-40.4M -158.4% | $-15.6M | — |
| Operating Income | $-26.3M -79.5% | $-14.7M | — |
| EPS (Diluted) | $-4.65 +98.1% | $-242.04 | — |
| Total Assets | $169.9M +294.4% | $43.1M | — |
| Total Debt | $14.9M +1.7% | $14.7M | — |
| Operating Cash Flow | $-28.6M -102.3% | $-14.1M | — |
| Free Cash Flow | $-36.0M -98.4% | $-18.2M | — |
Get alerted when SI's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for SHOULDER INNOVATIONS, INC. including:
Top Institutional Holders of SI
FMR LLC
$74.5M3,673,960 shBlackRock, Inc.
$12.9M638,420 shSECTORAL ASSET MANAGEMENT INC
$8.7M430,407 shVANGUARD CAPITAL MANAGEMENT LLC
$8.0M392,181 shKCM Capital Inc
$6.1M300,000 shTimesSquare Capital Management, LLC
$6.0M298,219 shRoubaix Capital, LLC
$5.2M255,288 shDRIEHAUS CAPITAL MANAGEMENT LLC
$5.1M253,760 shParkman Healthcare Partners LLC
$4.6M226,212 shGEODE CAPITAL MANAGEMENT, LLC
$4.0M199,529 sh
| Fund | Value | Shares |
|---|---|---|
| FMR LLC | $74.5M | 3,673,960 |
| BlackRock, Inc. | $12.9M | 638,420 |
| SECTORAL ASSET MANAGEMENT INC | $8.7M | 430,407 |
| VANGUARD CAPITAL MANAGEMENT LLC | $8.0M | 392,181 |
| KCM Capital Inc | $6.1M | 300,000 |
| TimesSquare Capital Management, LLC | $6.0M | 298,219 |
| Roubaix Capital, LLC | $5.2M | 255,288 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | $5.1M | 253,760 |
| Parkman Healthcare Partners LLC | $4.6M | 226,212 |
| GEODE CAPITAL MANAGEMENT, LLC | $4.0M | 199,529 |
Companies Similar to SI
Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.
CARLSMED, INC.
Alpha Teknova, Inc.
Ceribell, Inc.
Cryoport, Inc.
MiniMed Group, Inc.
Tarsus Pharmaceuticals, Inc.
Syndax Pharmaceuticals Inc
Kura Oncology, Inc.
Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.
More Healthcare Companies
View all Healthcare →Put SI on your watchlist
Track score changes the day SHOULDER INNOVATIONS, INC. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is SI a good stock to buy?
13F Pro's AI-powered analysis of SHOULDER INNOVATIONS, INC. (SI) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for SI are available on the SI stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. SI is classified as a small company.
Which hedge funds own SI?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling SI. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of SHOULDER INNOVATIONS, INC.'s investment landscape.